Evidence map›Paper›PMID 27994142›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival.

Débora R Bublik, Slađana Bursać, Michal Sheffer, Ines Oršolić, Tali Shalit, Ohad Tarcic, Eran Kotler, Odelia Mouhadeb, Yonit Hoffman, Gilad Fuchs and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Débora R BublikDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
Slađana BursaćDepartment of Molecular Medicine and Biotechnology, School of Medicine, University of Rijeka, Rijeka 51000, Croatia.
Michal ShefferDepartment of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel.
Ines OršolićDepartment of Molecular Medicine and Biotechnology, School of Medicine, University of Rijeka, Rijeka 51000, Croatia.
Tali Shalitde Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot 76100, Israel.
Ohad TarcicDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
Eran KotlerDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
Odelia MouhadebDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
Yonit HoffmanDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
Gilad FuchsDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
Yishai Levinde Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot 76100, Israel.
Siniša VolarevićDepartment of Molecular Medicine and Biotechnology, School of Medicine, University of Rijeka, Rijeka 51000, Croatia.
Moshe OrenDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel; moshe.oren@weizmann.ac.il.
Weizmann Institute of Science · ILUniversity of Rijeka · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microRNA miR-504 targets TP53 mRNA encoding the p53 tumor suppressor. miR-504 resides within the fibroblast growth factor 13 (FGF13) gene, which is overexpressed in various cancers. We report that the FGF13 locus, comprising FGF13 and miR-504, is transcriptionally repressed by p53, defining an additional negative feedback loop in the p53 network. Furthermore, we show that FGF13 1A is a nucleolar protein that represses ribosomal RNA transcription and attenuates protein synthesis. Importantly, in cancer cells expressing high levels of FGF13, the depletion of FGF13 elicits increased proteostasis stress, associated with the accumulation of reactive oxygen species and apoptosis. Notably, stepwise neoplastic transformation is accompanied by a gradual increase in FGF13 expression and increased dependence on FGF13 for survival ("nononcogene addiction"). Moreover, FGF13 overexpression enables cells to cope more effectively with the stress elicited by oncogenic Ras protein. We propose that, in cells in which activated oncogenes drive excessive protein synthesis, FGF13 may favor survival by maintaining translation rates at a level compatible with the protein quality-control capacity of the cell. Thus, FGF13 may serve as an enabler, allowing cancer cells to evade proteostasis stress triggered by oncogene activation.

Indexed as

Cell Line, TumorCell SurvivalFibroblast Growth FactorsHumansMicroRNAsNeoplasmsRibosomesTumor Suppressor Protein p53fibroblast growth factor 13Fibroblast Growth FactorsMicroRNAsMIRN504 microRNA, humanTP53 protein, humanTumor Suppressor Protein p53FGF13miR-504p53proteostasisribosomal biogenesis

Identifiers

PMID27994142
PMCPMC5278483
OpenAlexW2567615400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.